In Silico Presentations

Please click on a link below to watch one of our strategic In Silico presentations

Implementation of a Weight of Evidence Carcinogenicity Assessment Aligned with ICH S1B

This presentation reviews the state-of-the-art in assessing carcinogenicity based on the ICH S1B weight of evidence (WoE) addendum, including progress towards developing a transparent and defendable protocol based on the 6 WoE factors.

Presented by Glenn Myatt, PhD, SVP of In Silico & Translational Science Solutions, Instem, Arianna Bassan, Principal Consultant, Innovatune and Frances Hall, PhD, Senior Director, In Silico Solutions, Instem

Watch Now

Assessing N-nitrosamine Potency Classes

This presentation reviews recent regulatory and industry updates in the assessment of N-nitrosamine potency classes based on various collaborations. It outlines new defendable methods, including SAR and read-across approaches, based on a mechanistic understanding of N-nitrosamine carcinogenicity.  

Presented by Kevin Cross, PhD, VP of Product Development, Instem & Arianna Bassan, Principal Consultant, Innovatune

Watch Now


Contact Instem by phone

USA Headquarters

610 941 0990

UK Headquarters

+44 (0) 1785825600

Office Address

Diamond Way
Stone Business Park
Stone, Staffordshire
ST15 0SD
United Kingdom